In aspirin-treated platelets the thrombin-induced increase of cytosolic Ca2l ([Ca21],) associated with the release from the intracellular stores is followed by a decrease to the baseline which is largely dependent on the re-uptake into the stores. This is shown by the further increase of [Ca2+]i upon inhibition of the endomembrane Ca2+-ATPase with thapsigargin. The re-uptake of Ca2+ into the stores is accelerated by sodium nitroprusside (SNP) or prostacyclin (PGI2). In all cases, after store depletion with thapsigargin the influx of-external Ca2+ is maximal. After a thrombin-induced cycle of Ca2+-release re-uptake the stores are partly full: in these conditions the addition of external Ca2+ elicits a significant increment of [Ca2+] 
INTRODUCTION
Like other cells, platelets have a complex mechanism of Ca2+ signalling, involving the operation and interaction of Ca2+ sequestration into, and release from, -the intracellular stores, and of Ca2`influx from, and release to, the extracellular environment. In the absence of extracellular Ca2+, the Ca2l released from the stores by the agonist-generated inositol 1, 4, is readily re-accumulated into the stores by an ATP-energized Ca2+ pump [1, 2] , which is inhibited by thapsigargin [3] [4] [5] . By inhibiting the endomembrane Ca2+-ATPase, thapsigargin promotes Ca2+ release from the stores also in the absence of an agonist. If the cyclo-oxygenase pathway is inhibited, the thapsigargin-promoted Ca2+ release is not accompanied by an increase of IP3 [6] ; in these conditions, however, the Ca2+ released from the intracellular stores is 50 % or less of the total agonistdischargeable Ca2+ and an agonist like thrombin is required for full discharge [1, 7] . These observations led to the proposal of a two-pool model for Ca2+ in platelets, a thapsigargin-sensitive store and an agonist-releasable compartment [1, 2, 6] .
In the presence of extracellular Ca2", platelet activation is also accompanied by the influx of Ca2+ from the extracellular environment. The modes of Ca2+ influx in cells have been the object of considerable attention in recent years. In general, it was established that Ca2+ entry can be activated either directly by the interaction of agonists with their receptors, or indirectly by the depletion of the intracellular stores [8, 9] .
In platelets it was shown with stopped flow fluorimetry that ADP evokes a biphasic elevation of intracellular Ca2+ conplatelets at the moment of adding Ca2l. The thrombin-activated Ca2l influx is reversed by hirudin. A PGI2-and SNP-sensitive Mn2+ influx is observed if Mn2+ is added in place of Ca2+. It is concluded that thrombin activates a cyclic nucleotide-sensitive Ca2+ (and Mn2+) influx pathway dependent on the occupancy of the thrombin receptor and independent of the filling state of the stores. In the absence of thrombin, thapsigargin releases Ca2+ relatively rapidly from a fraction of the stores; the remaining deposits are discharged much more slowly. This may indicate that platelets contain two distinct classes of agonist-sensitive stores. The addition of external Ca2+ (or Mn2+) at short or long incubation times with thapsigargin monitors the influx of Ca2+ activated by the depletion of one [10] . It appears to be conducted by an ADP-receptor-operated non-selective cation channel [11, 12] . The second phase appears to coincide with and be caused by the release of Ca2+ from the intracellular stores [10] . Both phases are associated with the entry of Mn2+ and therefore, it was assumed, with Ca2+ entry. Depleting the intracellular stores with the endomembrane Ca2+-ATPase inhibitor thapsigargin or 2,5-di(tbutyl)-1,4-benzohydroquinone, in the absence of an agonist, promotes Ca2+ and Mn2' entry, proving directly that Ca2+ influx is activated by store depletion [13] [14] [15] .
Upon stimulation with agonists other than ADP, the onset of the increase of [Ca2+], was reported to be much less affected by the presence of extracellular Ca2+ [15, 16] . With thrombin, it was initiated some 280 ms after the addition of the agonist and it appeared to be anticipated only by 50- 
Platelet preparation
Platelet-rich plasma (PRP) and washed platelets were treated with aspirin and prepared as previously reported [18] from fresh blood drawn from healthy volunteers and mixed with acid citrate-dextrose anticoagulant supplemented with apyrase (80 m-units/ml) and prostacyclin (0.8 ,ug/ml).
Determination of [Ca2+],
The cytosolic Ca2+ concentration was determined with Fura-2AM essentially according to Pollock and Rink [19] . The probe (2 ,uM) [21] .
Mn2+ influx
This was monitored as the quenching of Fura-2 fluorescence, with the excitation and emission wavelength set at 360 and 505 nm as indicated by [22] . Platelets were treated with 0.2 mM CaCl2 for 2 [1] ).
The decay of [Ca2+]i elevated by thrombin is accelerated if PGI2 or the nitroxide radical generator SNP, which mediate the production of cyclic AMP and cyclic GMP respectively, are supplemented at the peak of the thrombin-induced Ca2+ transient (see also [2, 23] ). This appears to be the consequence of a stimulated re-uptake into the stores, since: (1) is observed, both in the absence and presence of PGI2 and SNP, when Ca2+ is supplemented to the incubation medium after thapsigargin treatment, that is when the stores are depleted. This is expected, since the emptying of the agonist-sensitive Ca2+ deposits has been reported to stimulate Ca2+ influx [13, 14] . On the contrary, if Ca2+ is supplemented to the suspending medium before the addition of thapsigargin, i.e. when the stores are partially refilled after their transient depletion by thrombin Figure 1 . Where indicated, CaCd2 was 0.6 and 2.5 mM, and EGTA 1 mM.
Enough NaOH was added at the second addition of Ca2+ to compensate for the H+ generated at the moment of complexation. Where indicated, PGI2 (---) was 0.7,ug/ml and SNP ( * ) 70 ,uM. * and ** represent the A[Ca2+]i observed before and after the addition of Ca2+ upon addition of thapsigargin plus ionomycin (*) and of EGTA (5 mM, plus NaOH) followed by thapsigargin plus ionomycin (**). A possible objection to the conclusions reached in Figure 2 is that after the thrombin-induced cycle of Ca2+ release-re-uptake, the Ca2+ content of the stores is significantly less than that of unstimulated platelets. This makes a contribution of the storedependent activation of Ca2+ influx likely. Indeed, in Figure 2 , a sizeable increment of the stores-associated Ca2+ was observed, after the addition of Ca2+, in the presence of PGI2 also. This could represent Ca2+ influx activated by residual store depletion. The experiment of Figure 3 Figure 2 in Figure 4 where, after a cycle of store depletion-refilling induced by thrombin, the increase of [Ca2+] was strongly reduced if hirudin was supplemented 5 min before the addition of Ca2 . Taken together, these findings show that thrombin does indeed activate a type of Ca2+ influx which is independent of the filling state of the stores and is inhibited by the removal of thrombin, as well as by PGI2 and SNP.
The influx of Mn2+ has been used as a tracer for Ca2+ entry in several cell types, including platelets. At the excitation wavelength of 360 nm, the Mn2+-induced quenching of the Fura 2 fluorescence is not affected by [Ca2+]i. As shown in Figure 5 the addition of Mn2+ after a cycle of thrombin-induced depletionrefilling of the Ca2+ stores promotes a quenching of the Fura 2 fluorescence, which is inhibited by PGI2 and SNP. This experiment indicates that the thrombin-activated, cyclic nucleotides-sensitive Ca2+-entry system described above is also permeable to Mn2 .
The sequential depletion of the two types of Ca2+ stores activates a progressively increased, PGI2-and SNP-lnsensitive Influx of Ca2+ and Mn2+
It is generally agreed that the increase of [Ca2+]1 promoted by thapsigargin is due to a leak from the stores the Ca2+-ATPase of which is inhibited. As already described [1, 2, 6, 13] , thapsigargin depletes the agonist-sensitive stores only partially in aspirintreated platelets. The emptying of the deposits is completed by thrombin. On the contrary, the thapsigargin-induced depletion is complete if it is added after the thrombin-promoted cycle of store depletion-re-replenishment [1, 2] . These properties were taken as evidence that two types of Ca2+ stores exist in platelets, one discharged by thapsigargin and the other by the agonist [1, 2, 6] .
In Figure 6 we report experiments showing that a low concentration (50 nM) of ionomycin can substitute for thrombin in completing the release into the cytosol of the Ca2+ associated with the agonist-sensitive stores promoted by thapsigargin. In fact, the addition ofthrombin in the presence of both thapsigargin and ionomycin (added in either order) elicits no further increase of [Ca2+]1. (At these low concentrations ionomycin releases Ca2+ preferentially from the agonist-sensitive stores and only marginally from the secretory granules [24] , which contain most of the platelet Ca2+ [25] .) A likely explanation for these observations is that the stores which are not readily discharged by thapsigargin are characterized by a low Ca2+ leak in the absence of a suitable agonist, so that the inhibition of their Ca2+ pump does not lead to a ready Ca2+ release, unless an artificial leak is introduced. Indeed, a sizeable leak is present also in the absence of ionomycin, since increasing the time of incubation after thapsigargin addition leads to a progressive discharge of the thapsigargin-insensitive stores also [2] . This is shown in Figure 7 (a) where thrombin added at the top of the thapsigargin-induced increase of [Ca2+]1 releases a large further amount of Ca2+; it releases much less Ca2+ if it is added 20 min later. It is therefore possible to decrease sequentially the Ca2+ content of the two types of agonist-sensitive stores, simply by incubating platelets in the presence of thapsigargin for long enough times. This allows us to study Ca2+ (and Mn2+) influx when only the thapsigargin-sensitive stores are empty, as well as when the other stores also (less readily discharged by thapsigargin) are depleted.
As shown in Figure 7 (b) the addition of Ca2+ 1 min after thapsigargin, i.e. when only the first class of Ca2+ deposits is empty, is followed by an increase of [Ca2+]i which is much slower and less extensive than that observed when Ca2+ is added 20 min after thapsigargin, when the second type of Ca2+ deposits is also largely depleted. This indicates that the filling state of each type of Ca2+ store controls the activation of Ca2+ influx. In this case, the addition of PGI2 or SNP before Ca2+ is without effect on the increase of [Ca2+]1. The insensitivity to cyclic nucleotides differentiates the Ca2+-influx pathway that is activated by the depletion of the stores from that controlled by the occupancy of the thrombin receptor.
The dependence of Mn2+ influx on the differential depletion of the stores was studied by adding Mn2+ to the suspending medium, in the pjace of Caa2+, after a short or a long incubation time with thapsigargin ( Figure 8 ). The properties of Mn2+ influx were similar to those just described for Ca2 , i.e. a slow entry after the depletion of the first stores, which was strongly increased by the depletion of the second stores. PGI2 and SNP had no effect on this type of Mn2' entry.
DISCUSSION
The pathways of Ca2+ influx in platelets with agonists other than ADP are controversial. With thrombin, stopped-flow experiments indicate that the increase of [Ca2+]i, in the presence of extracellular Ca2 , precedes, but only by 50-100 is, that observed without Ca2+ in the suspending medium [15] . This was taken as an indication of the existence of a receptor-activated Ca2+-influx pathway operating prior to the store depletion-activated entry. This view was not shared by Alonso et al. [14] . The observations reported in the present research prove the existence of a Ca2+-entry pathway activated by the occupancy of the thrombin receptor and independent of the filling state of the stores. This conclusion was reached taking advantage of the property of th-rombin to promote a rapid Ca2+ release from the stores into the cytosol, followed readily by the re-uptake into the deposits of part of the Ca2+ released. After this cycle of Ca2+ release-reuptake, the addition of Ca2+ is followed by Ca2+ influx. The latter is largely unrelated to the store-controlled Ca2' entry, since (1) it is also observed if the Ca2+ content of the stores at the moment of supplementing Ca2+ is increased to a level comparable with that of unstimulated platelets, and (2) it is prevented by hirudin, added before the addition of Ca2+ to terminate the action of thrombin. The thrombin-dependent Ca2+ influx is inhibited by PGI2 as well as by SNP. These agents are without effect on Ca2+ influx activated by the depletion of the stores. Also Mn2+ is permeable through the thrombin-activated Ca2+-entry pathway. The PGI2-and SNP-sensitive Mn2+ entry is relatively slow. This may have rendered its detection difficult in stopped-flow experiments [15] . Interestingly, PGI2 and SNP, which inhibit the thrombin-receptor-activated Ca2+ (Mn2+) influx, are without effect on the ADP-receptor-activated influx [16, 26] . The present experiments do not allow us to propose a mechanism for the inhibition by cyclic AMP and cyclic GMP of the thrombindependent Ca2+ (Mg2+) influx. As the action of thrombin requires a continuous receptor occupancy, being counteracted by hirudin, the cyclic nucleotides may inhibit the generation of continuously metabolized signal molecules that cause Ca2+ entry. Alternatively, [27, 28] and with the activation of phospholipase C [29, 30] . It also increases the incorporation of diacylglycerol into phosphatidylinositol [31] and it inhibits events distal to Ca2+ mobilization [32, 33] and the activation of protein kinase C [18, 34] . Similarly cyclic GMP interferes with the activation of phospholipase C [26, [35] [36] [37] [38] and with distal processes [39, 40] . Furthermore, cyclic GMP potentiates the action of cyclic AMPelevating stimuli by inhibiting the cyclic AMP phosphodiesterase [41] . The cyclic nucleotides increase the rate of Ca2+ re-uptake into the stores after their discharge with thrombin ( [1, 2, 23] and Figure 1 ). The present experiments do not allow us to establish the mechanism of the cyclic nucleotides-stimulated Ca2+ reuptake. Factors involved could be a decreased level of IP3, an inhibition of the IP3-activated Ca2+ release (as reported for cyclic AMP [42] [43] [44] ) or an activation of the Ca2+-ATPase (as again reported for cyclic AMP [23, [45] [46] [47] [48] [49] [50] , but see [51, 52] ).
Recent studies with the endomembrane Ca2+-ATPase inhibitor thapsigargin led to the hypothesis that platelets contain two distinct types of agonist-sensitive Ca2+ storage sites, one discharged by thapsigargin and the second by thrombin [1, 2, 6, 53] . In fact, in platelets treated with aspirin or with a thromboxane A2-receptor inhibitor, and in the absence of extracellular Ca2 , thapsigargin promotes the release into the cytosol of only a fraction of the stores-associated Ca2+. The remaining Ca2+ is released only by an agonist like thrombin. On the other hand, thrombin promotes a fast release into the cytosol of the Ca2+ associated with the stores, and most of the Ca2+ released is then rapidly re-accumulated-into the deposits. Interestingly, after a cycle of thrombin-induced depletion-refilling of the deposits, thapsigargin promotes the complete discharge into the cytosol of the Ca2+ re-accumulated [1] . This could mean that, after thrombin, Ca2+ is re-accumulated exclusively into the thapsigarginsensitive stores, or alternatively that the presence of the agonist enables thapsigargin to stimulate the release of Ca2+ from both types of stores. We favour the latter possibility because, as shown in Figure 6 , ionomycin can substitute for thrombin in potentiating the Ca2+-releasing effect of thapsigargin. This Figure 6 ). Indeed, two types of endoplasmic reticulum Ca2+ pump isoforms have been described in platelets, which are both inhibited by sufficiently high thapsigargin concentrations [54, 55] . Furthermore, as already suggested [2] , the stores that do not release their Ca2+ readily after thapsigargin are not insensitive to its action, since they are also depleted, but in a longer time frame.
We utilized this property to show that the depletion of both types of stores is associated with the activation of Ca2+ influx from the extracellular space: in fact, a short (1 min) incubation with thapsigargin before addition of Ca2l to the suspending medium is associated with the depletion of the thapsigarginsensitive stores and with a limited Ca2+ influx. The latter is much less than that observed if Ca2+ is added 20 min after thapsigargin, when the second class of Ca2+ deposits is also largely depleted.
The influx of Mn2+ follows the same pattern: the thapsigargininduced depletion of the first class of stores activates a slow Mn2+ entry and the rate increases substantially when the second class of stores is also depleted.
The nature of the signal(s) leading to the activation of Ca2+ influx upon depletion of the stores is still not well understood. It was proposed to be linked to some cytochrome P-450-dependent function, as Ca2+ influx was reported to be inhibited by the antifungal agents, cytochrome P-450-inhibitors econazole and miconazole [14] . In platelets, these substances were reported to act on both types of Ca2+ influx [14] , or alternatively only on the influx activated by thapsigargin, but not on that activated by thrombin [13] . Quite recently, it was proposed that Ca2+ efflux from the stores is accompanied by the release into the cytosol of a low-molecular-mass phosphorylated agent that would activate Ca2+ influx; the action of this agent was reported to be inhibited by econazole [56] .
If these data are confirmed, this would indicate that the agent is released by the emptying of both types of Ca2+ storage granules associated with the platelets.
In summary the results reported in this study show that thrombin activates a store-depletion-independent Ca2+ influx in platelets, observed by adding Ca2+ after a cycle ofstore depletionrefilling. Such influx is inhibited by the removal of thrombin with hirudin. It is also inhibited by PGI2 and SNP. A PGI2-and SNPsensitive Mn2+ influx can also be observed in the same conditions. In the absence of the agonist, thapsigargin promotes the rapid depletion of a fraction of the Ca2+ stores and the slow depletion of the remaining stores. The influx of Ca2+ (and Mn2+) is activated by the depletion of the stores: it is relatively limited if only the first type of Ca2+ deposits is emptied and much larger when extensive depletion of the stores is obtained after 20-30 min of incubation with thapsigargin. This type of Ca2+ and Mn2+ influx is insensitive to PGI2 and SNP.
